LEADER 02451nam 2200613 a 450 001 9910815408503321 005 20240417010203.0 010 $a1-280-38012-8 010 $a9786613558039 010 $a0-309-21436-X 035 $a(CKB)2550000000103133 035 $a(EBL)3378972 035 $a(SSID)ssj0000648355 035 $a(PQKBManifestationID)11417834 035 $a(PQKBTitleCode)TC0000648355 035 $a(PQKBWorkID)10597632 035 $a(PQKB)10254351 035 $a(Au-PeEL)EBL3378972 035 $a(CaPaEBR)ebr10557791 035 $a(CaONFJC)MIL355803 035 $a(OCoLC)755123852 035 $a(MiAaPQ)EBC3378972 035 $a(EXLCZ)992550000000103133 100 $a20120217d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAdverse effects of vaccines$b[electronic resource] $eevidence and causality /$fInstitute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$d2012 215 $a1 online resource (895 p.) 300 $a"Committee to Review Adverse Effects of Vaccines ; Board on Population Health and Public Health Practice." 311 $a0-309-21435-1 320 $aIncludes bibliographical references and index. 327 $aApproach -- Evaluating biological mechanisms of adverse events -- Measles, mumps, and rubella vaccine -- Varicella virus vaccine -- Influenza vaccine -- Hepatitis A vaccine -- Hepatitis B vaccine -- Human papillomavirus vaccine -- Diphtheria toxoid-, tetanus toxoid-, and acellular pertussis-containing vaccines -- Meningococcal vaccine -- Injection-related adverse events -- Concluding comments. 606 $aVaccination$xComplications 606 $aBacterial diseases$xPrevention 606 $aVirus diseases$xPrevention 615 0$aVaccination$xComplications. 615 0$aBacterial diseases$xPrevention. 615 0$aVirus diseases$xPrevention. 676 $a615.3/72 701 $aStratton$b Kathleen R$01593160 712 02$aInstitute of Medicine (U.S.).$bCommittee to Review Adverse Effects of Vaccines. 712 02$aInstitute of Medicine (U.S.).$bBoard on Population Health and Public Health Practice. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910815408503321 996 $aAdverse effects of vaccines$93920358 997 $aUNINA